Two Galway-based medical technology companies, NeoSurgical and APICA Cardiovascular, have been short-listed for the Emerging Medical Technology Company of the Year Award 2012.
The Medical Technology Industry Excellence Awards are jointly hosted by Enterprise Ireland, IDA Ireland and IMDA. Eight companies have been short-listed, four for the Company of the Year Award and four for the Emerging Company of the Year Award. The winners will be announced on Thursday, 13 December at an event in Galway.
NeoSurgical Ltd was short-listed for its project to innovate for the global minimally invasive surgery market with its first device NeoClose.
APICA Cardiovascular Ltd was short-listed for its Access, Stabilisation and Closure (ASCTM) device, which is used in heart surgery.
There was a ten per cent increase in medical technology exports for the first six months of the year, according to the Irish Medical Device Association (IMDA), the IBEC group that represents the medical technology sector.
The figures show medical technology exports valued at €3.93 billion for the first six months of the year, compared to €3.57 billion for the same period last year.
The figures were highlighted as the short-list for the 2012 Medical Technology Excellence Awards were announced.
Commenting on the short-list, Dr Brian O’Neill, Manager Life Sciences at Enterprise Ireland said the medical technologies industry is of key importance to the Irish economy and has continued to grow year on year.
“25,000 people are directly employed in the sector in Ireland. Ireland is home to nine out of the world’s top ten leading multinationals, including Boston Scientific, Medtronic, Cordis, DePuy, Stryker, Covidien, Baxter, Abbott and Cook Medical as well as a very strong base of innovative indigenous companies.
“The sector in Ireland has developed to global standard characterised by global excellence and leadership in world class manufacturing, lean business, innovative R&D, new product development and global success. The standard of entries for this year’s awards was extremely high and reflected the continuing evolution of the medical technologies industry across Ireland.”